Reported covered position: Senior Manager of Policy and Government Affairs
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
New Era of Preventing End-Stage Kidney Disease Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2026 · third_quarter · Q3
-$51.303B in appropriations for NIH in FY27 (to support investments in basic, clinical, translational, and other health-related research activities) -$1 billion in appropriations for kidney research at NIDDK within the overall NIDDK FY27 appropriation, implementing the recommendations of the Transforming Kidney Health Research report -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for significant revision or recision of the proposed Regulation for Federal Financial Assistance
Source: Senate LDA
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Expanding Support for Living Donors Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
Expanding Support for Living Donors Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Expanding Support for Living Donors Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Diabetes Foot Health Access and Modernization Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
H–1Bs for Physicians and the Healthcare Workforce Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Provider Reimbursement Stability Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
KIDNEY Remote Monitoring Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
KIDNEY Remote Monitoring Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Answering the Call Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Answering the Call Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Improving Home Dialysis Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Improving Home Dialysis Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Kidney Disease Education Access Expansion Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Kidney Disease Education Access Expansion Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Diabetes Foot Health Access and Modernization Act of 2026
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
Organ Donation Referral Improvement Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
Removing Burdens From Organ Donation Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
Removing Burdens From Organ Donation Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
To amend the Family and Medical Leave Act of 1993 and title 5, United States Code, to clarify that organ donation surgery qualifies as a serious health condition.
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
CONNECT for Health Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
Living Donor Protection Act of 2025
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
Sickle Cell Disease Comprehensive Care Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
Honor Our Living Donors Act
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
Living Donor Protection Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Living Donor Protection Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Living Donor Protection Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (forthcoming legislation) Lifetime immunosuppressive drug coverage for kidney transplant recipients
Living Donor Protection Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Electronic Court Records Reform Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Electronic Court Records Reform Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Electronic Court Records Reform Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Living Donor Protection Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Living Donor Protection Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Living Donor Protection Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Living Donor Protection Act of 2019
Client: AMERICAN SOCIETY OF NEPHROLOGY · Firm: AMERICAN SOCIETY OF NEPHROLOGY
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (forthcoming legislation) Lifetime immunosuppressive drug coverage for kidney transplant recipients
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -KIDNEY Remote Monitoring Act (HR 8319) -Living Organ Volunteer Engagement (LOVE) Act (H.R. 7581) and related concepts that could be clarified administratively -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, as well as advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model, including a focus on upstream kidney care and earlier intervention -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Discussed importance of greater emphasis on kidney health, prevention, and earlier disease detection and intervention -Encouraged support for KidneyX
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2026 · second_quarter · Q2
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -Concurrent Care for Comfort Act (HR 8367) and related policy concepts regarding helping patients on dialysis nearing end of life also access hospice care -Home Dialysis Improvement Act (HR 8875) and related policy concepts helping more patients consider electing home dialysis -Kidney Disease Education Expansion Act of 2026 (H.R. 9509) and related policy concepts to increase earlier upstream intervention to slow the progression of kidney disease, including screening and diagnosis -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Encouraged CMMI to develop a subsequent kidney care focused model, building on the successes and lessons of the CKCC model -Asked questions about the adequacy of kidney patient access to specialized kidney and transplant care in MA plans -Endorsed the following bills: -Keeping Individuals with Dialysis Needs Equipped through Year-round (KIDNEY) Remote Monitoring Act (HR 8319) Provider Reimbursement Stability Act (HR 8163) -The Diabetes Foot Health Access and Modernization Act of 2026 (HR 7905/S 4070) -H-1Bs for Physicians and Healthcare Workforce Act (HR 7961) Living Organ Volunteer Engagement (LOVE) Act (HR 7581) -New Era of Preventing ESRD Act (HR 1518) -PKD Cures Act (HR 9169)
-$51.303B in appropriations for NIH in FY27 (to support investments in basic, clinical, translational, and other health-related research activities) -$1 billion in appropriations for kidney research at NIDDK within the overall NIDDK FY27 appropriation, implementing the recommendations of the Transforming Kidney Health Research report -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for significant revision or recision of the proposed Regulation for Federal Financial Assistance
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2026 · first_quarter · Q1
-$51.303B in appropriations for NIH in FY27 (to support investments in basic, clinical, translational, and other health-related research activities) -$1 billion in appropriations for kidney research at NIDDK within the overall NIDDK FY27 appropriation, implementing the recommendations of the Transforming Kidney Health Research report -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)
-Expanding Support for Living Donors Act (H.R. 7868) Legislation to expand how much living donors can be reimbursed and to increase the threshold for income-based qualification -Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$77M in appropriations for HRSA Organ Transplant work in FY27 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY27 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for continued focus on modernizing the U.S. transplant system, including implementing the 2023 Securing the U.S. OPTN Act -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including advancing data-sharing, data standards, and interoperability -Raised questions about access to and quality of care in Medicare Advantage plans for kidney patients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2025 · fourth_quarter · Q4
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged HHS to ensure kidney health data remains accessible and complete, including collection of key demographic information via form 2728
-$51.303B in appropriations for NIH in FY26 (to support investments in basic, clinical, translational, and other health-related research activities) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2025 · third_quarter · Q3
-Honor Our Living Donors Act (H.R. 628 / S. 957) Legislation to simplify the process of determining eligibility for reimbursement for living kidney donation-related costs -CONNECT for Health Act (S. 1261) Legislation to expand the use of telehealth and remote patient monitoring services in Medicare on a permanent basis -Organ Donation Referral Improvement Act (H.R. 330) Calls for study on adoption and best practices in automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations -Removing Barriers for Organ Donation Act (H.R.4470) Mandates implementation of automated referral regarding potential organ donors from donor hospitals to local organ procurement organizations, with exceptions, and calls for a GAO study and agency coordination -Living Donor Protection Act (H.R. 4583) and related FMLA bill (H.R. 4582 and S. 1552). Clarifies and strengthens protections for Americans who donate an organ. - H.R. 5178, Sickle Cell Disease Comprehensive Care Act Authorizes state Medicaid Programs to provide comprehensive coordinated care through a Home Health program. (Senate companion S. 721) -$67M in appropriations for HRSA Organ Transplant work in FY26 (funding to modernize the US transplant system and support living donors through reimbursement for living kidney donation-related costs) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions) -Called for HRSA to focus on transparency for patients, improvements to data use and management, and attention to allocation out of sequence issues as it implements the 2023 Securing the US OPTN Act and FY25 appropriations -Called for the creation of an Officer of Kidney Health and Transplantation within the immediate office of the secretary of HHS (to coordinate kidney health care, research, and data-related efforts across the numerous HHS agencies with a role in kidney health) -Urged CMS to ensure kidney health data, particularly through the EQRS, remains readily available to the kidney research community as well as to the USRDS -Urged additional improvements to kidney care models at CMMI, particularly CKCC and IOTA - Urged Department of Homeland Security to not impose restrictions on physician visas, including to waive the $100,000 application fee for H1b visas, not implement new weighted tier system for H1b visa availability, and responded to proposal to modify current Duration of Status for J1 visa holders.
-$51.303B in appropriations for NIH in FY26 (to support investments in basic, clinical, translational, and other health-related research activities) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2025 · second_quarter · Q2
-$51.303B in appropriations for NIH in FY26 (to support investments in basic, clinical, translational, and other health-related research activities) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2025 · first_quarter · Q1
-$51.303B in appropriations for NIH in FY26 (to support investments in basic, clinical, translational, and other health-related research activities) -$25M in appropriations for HHS in FY26 to support KidneyX (public-private partnership to catalyze innovation in kidney disease prevention, diagnosis, and treatment through a series of prize competitions)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · fourth_quarter · Q4
FY 25 Congressional appropriations: -Increase NIH funds, including proportional increase for NIDDK to support kidney research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies Regulatory: Prioritize kidney health research, including inside the NIH Ensure training grants established by the NIH are supportive of the kidney health workforce
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · third_quarter · Q3
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program Regulatory: Prioritize kidney health research, including inside the NIH Ensure training grants established by the NIH are supportive of the kidney health workforce
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · second_quarter · Q2
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program Regulatory: Prioritize kidney health research, including inside the NIH Ensure training grants established by the NIH are supportive of the kidney health workforce
Filing targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2024 · first_quarter · Q1
FY 24 and FY 25 Congressional appropriations: -Increase funding for Health Resources and Services Administration (HRSA) Organ Transplantation Program -Increase NIH funds, including proportional increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program -Increase DoD Congressionally Mandated Medical Research Program Regulatory: Prioritize kidney health research, including inside the NIH
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2023 · fourth_quarter · Q4
Legislative: FY24 Congressional appropriations: -Increase NIH funds by $3.465 billion, including $168 million increase for NIDDK to support kidney research and $150 million for a Special Statutory Funding Program for Kidney Research -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations innovative kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative -Increase funding Veterans Health Administration Kidney Health Program by $40 million -Increase DoD Congressionally Mandated Medical Research Program by $15 million Regulatory: Prioritize kidney health research, including inside the NIH
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · third_quarter · Q3
FY22 Congressional appropriations: -Increase NIH funds, supporting $6.5 billion for NIH in general, including $2.2 billion for kidney research at NIDDK -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies -Support CDC Chronic Kidney Disease Initiative at $5 million
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · second_quarter · Q2
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · first_quarter · 1A
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2021 · first_quarter · Q1
FY22 Congressional appropriations: -Increase NIH funds overall of at least $46.111 billion, providing a proportionate increase for the NIDDK of at least $157 million -Provide supplemental emergency funding of $10 billion for NIH and ensure dedicated support for the NIDDK to enable critical COVID-related research and to support research recovery from the impact of the pandemic. -Provide $25 million to KidneyX to continue development of an artificial kidney and other innovations kidney therapeutics and technologies
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · fourth_quarter · Q4
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills Increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · third_quarter · Q3
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills and $200M in emergency supplemental Increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · second_quarter · Q2
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills and $200M in emergency supplemental Increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2020 · first_quarter · Q1
Increased NIH and NIDDK funding in FY2021 House and Senate LHHS Appropriations Bills increased funding for research into connections between COVID-19 and the kidney in potential fourth emergency supplemental COVID funding package $25M funding for KidneyX in FY2021 House and Senate LHHS Appropriations Bills and increased funding for innovative product development through KidneyX to support the COVID-19 response and better prepare our kidney care system for subsequent COVID waves or other emergency situations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Federal Emergency Management Agency (FEMA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · fourth_quarter · Q4
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · third_quarter · Q3
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · second_quarter · Q2
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (S. 2064 "Organ Procurement Optimization Act") Lifetime immunosuppressive drug coverage for kidney transplant recipients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2019 · first_quarter · Q1
Increased NIH and NIDDK funding in FY2020 House and Senate LHHS Appropriations Bills $25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills
$25M funding for KidneyX in FY2020 House and Senate LHHS Appropriations Bills Legislation to create a mechanism to add novel new devices to the ESRD PPS bundle Living Donor Protection Act (S. 511 and H.R. 1224) Organ Procurement Organization metrics reform (forthcoming legislation) Lifetime immunosuppressive drug coverage for kidney transplant recipients
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · fourth_quarter · Q4
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX. Urged support for KidneyX program more generally.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · third_quarter · Q3
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX) including for FY2019 appropriations for KidneyX ($25 million). Urged Congressional support for KidneyX program more generally. Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY19 appropriations ($2.2 billion) Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · second_quarter · Q2
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX) including for FY2019 appropriations for KidneyX ($25 million) Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY19 appropriations ($2.2 billion) Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2018 · first_quarter · Q1
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator (KidneyX) including for FY2019 appropriations for KidneyX ($25 million) Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY19 appropriations ($2.2 billion) Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2017 · fourth_quarter · Q4
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY17 and FY18 appropriations Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF NEPHROLOGY via AMERICAN SOCIETY OF NEPHROLOGY
2017 · third_quarter · Q3
Discussed important of investments in kidney research at NIH, VA, and encouraged cross-collaboration on kidney research Advocated to advance kidney research and innovation, including kidney disease prize competition and accelerator Supported greater kidney research funding at NIH in general, and NIDDK in particular, for FY17 and FY18 appropriations Recommended Special Kidney Program for kidney research at NIDDK (appropriations)
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)